RxPharma AB
ActiveKey figures
Key figures
2025Summary: RxPharma AB
What kind of company is it?
RxPharma AB (org. no. 559446-2201) is a limited company (AB). The company was registered in 2023 and has existed for 3 years. Registered seat: Habo. Industry according to Statistics Sweden: temporary employment agency activities (SNI 78201).
How is the company doing financially?
Net sales in financial year 2025 were 512 815 kr, down 39,5 % on the previous year (847 685 kr). Net profit for 2025 was 130 913 kr (25,5 % of net sales). At the end of financial year 2025, total assets were 198 787 kr and equity 158 548 kr (equity ratio 79,8 %). The annual report for 2025 proposes a dividend of 133 500 kr.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 2 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 133 500 kr.
Summary of annual reports2024–2025
| 2024 | 2025 | |
|---|---|---|
| Sales revenue | 847 685 | 512 815 |
| Profit for the reporting year | 152 635 | 130 913 |
| Retained earnings of previous periods | — | — |
| Total assets | 272 301 | 198 787 |
| Total liabilities | 94 666 | 40 239 |
| Total equity | 177 635 | 158 548 |
| Employees | — | — |
| Proposed dividend | 150 000 | 133 500 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.